Company intelligence / Profile preview

Stolle Milk Biologics

West Chester, Ohio, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Stolle Milk Biologics' lead product, MicroLactin, is a proprietary milk protein concentrate clinically proven to reduce inflammation, improve immune function, and support gut health. The company claims investment in over 15 clinical studies and over 250 patents worldwide on its technology, with use in both human and animal health.

Therapeutic areas: ImmunologyOtherGastroenterology
Modalities: BiologicProtein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Stolle Milk Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stolle Milk Biologics.

Explore the full profile